-
Beam Therapeutics (NASDAQ:BEAM) Rating Increased to Outperform at Leerink Partners
Источник: Buzz FX / 06 ноя 2024 07:56:16 America/New_York
Beam Therapeutics (NASDAQ:BEAM) Rating Increased to Outperform at Leerink Partners Written by MarketBeat November 6, 2024 Share Link copied to clipboard. Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) was upgraded by Leerink Partners f
Read more...